CAS Medical Systems, Inc. Announces Publication in Congestive Heart Failure Journal of Study Demonstrating Value of FORE-SIGHT to Measure Cerebral Oxygenation

BRANFORD, Conn., April 4, 2012 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED) announced today the publication of a study illustrating the unique value that the Company's FORE-SIGHT™ Absolute Cerebral Oximeter offers for the evaluation of patients with congestive heart failure and related conditions. The paper, entitled "Initial Description of Cerebral Oximetry Measurement in Heart Failure Patients," was published in the March/April 2012 issue of Congestive Heart Failure Journal, and is available online at http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7133.2011.00284.x/full.